14. Antidepressant versus placebo: aggression results that could not be used in the meta‐analyses.
Study name | Short‐/ medium‐/ long‐term outcomes | Group 1 | Group 2 | Group 1 sample size | Group 2 sample size | Group 1 results | Group 2 results | Other data | Notes |
Carminati 2016 | Short‐term aggression | Venlafaxine 18.75 mg/day | Placebo | 6 | 7 | Median 3.5 (range 0‐18) | Median 4 (range 1‐9) | ‐ | Only median and range provided |
McDougle 1996 | Short‐term aggression | Fluvoxamine max 300 mg/day | Placebo | 15 | 15 | Not reported; only t scores and P value | Not reported; only t scores and P value | As measured by total score on the Brown Aggression Scale, fluvoxamine was superior to placebo in reducing aggression (F = 4.57; d = 3.84; P < 0.03). | ‐ |